NO177845C - Fremgangsmåte for fremstilling av et preparat for öyedråper - Google Patents

Fremgangsmåte for fremstilling av et preparat for öyedråper

Info

Publication number
NO177845C
NO177845C NO913136A NO913136A NO177845C NO 177845 C NO177845 C NO 177845C NO 913136 A NO913136 A NO 913136A NO 913136 A NO913136 A NO 913136A NO 177845 C NO177845 C NO 177845C
Authority
NO
Norway
Prior art keywords
composition
eye drops
preparing
benzoxadine
thioxo
Prior art date
Application number
NO913136A
Other languages
English (en)
Other versions
NO913136L (no
NO177845B (no
NO913136D0 (no
Inventor
Kazumichi Ushio
Yoshifumi Ikejiri
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Publication of NO913136D0 publication Critical patent/NO913136D0/no
Publication of NO913136L publication Critical patent/NO913136L/no
Publication of NO177845B publication Critical patent/NO177845B/no
Publication of NO177845C publication Critical patent/NO177845C/no

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO913136A 1990-08-13 1991-08-12 Fremgangsmåte for fremstilling av et preparat for öyedråper NO177845C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP21482790 1990-08-13
JP16285491 1991-07-03

Publications (4)

Publication Number Publication Date
NO913136D0 NO913136D0 (no) 1991-08-12
NO913136L NO913136L (no) 1992-02-14
NO177845B NO177845B (no) 1995-08-28
NO177845C true NO177845C (no) 1995-12-06

Family

ID=26488494

Family Applications (1)

Application Number Title Priority Date Filing Date
NO913136A NO177845C (no) 1990-08-13 1991-08-12 Fremgangsmåte for fremstilling av et preparat for öyedråper

Country Status (16)

Country Link
US (1) US5663170A (no)
EP (1) EP0472327B1 (no)
JP (1) JP2769253B2 (no)
KR (1) KR920003971A (no)
AT (1) ATE121295T1 (no)
AU (1) AU633754B2 (no)
CA (1) CA2048942A1 (no)
DE (1) DE69109021T2 (no)
DK (1) DK0472327T3 (no)
ES (1) ES2071227T3 (no)
FI (1) FI97777C (no)
HU (1) HU207950B (no)
NO (1) NO177845C (no)
PT (1) PT98643B (no)
RU (1) RU2068260C1 (no)
TW (1) TW200402B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993018764A2 (en) * 1992-03-18 1993-09-30 Coopervision Pharmaceuticals, Inc. VERAPAMIL HCl FORMULATION AND OTHER OPHTHALMIC SOLUTIONS WITH BUFFER SYSTEM FOR OCULAR ADMINISTRATION
US5324718A (en) * 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation
US5472954A (en) * 1992-07-14 1995-12-05 Cyclops H.F. Cyclodextrin complexation
AU5599594A (en) * 1992-11-16 1994-06-08 Ciba-Geigy Ag Polyvinyl alcohol/borate ophthalmic drug delivery system
US5494901A (en) * 1993-01-05 1996-02-27 Javitt; Jonathan C. Topical compositions for the eye comprising a β-cyclodextrin derivative and a therapeutic agent
SE501482C2 (sv) * 1993-06-24 1995-02-27 Leiras Oy Komposition för topisk administration av bispilokarpinsyradiestrar till ögat i form av en vattenlösning
WO1995003784A1 (en) * 1993-07-28 1995-02-09 Insite Vision Incorporated Suspensions for delivery of medicament
WO1996001558A1 (en) * 1994-07-11 1996-01-25 Pate David W Anandamide analogue compositions and method of treating intraocular hypertention using same
US5631297A (en) * 1994-07-11 1997-05-20 Pate; David W. Anandamides useful for the treatment of intraocular hypertension, ophthalmic compositions containing the same and methods of use of the same
JP3297969B2 (ja) * 1994-12-26 2002-07-02 ライオン株式会社 点眼剤
KR100261585B1 (ko) * 1995-01-20 2000-07-15 오쿠다 기요아키 항염증점안제
CA2210749C (en) * 1995-01-20 2001-04-10 Wakamoto Pharmaceutical Co., Ltd. Anti-inflammatory eye drop
US6476004B1 (en) 1996-07-18 2002-11-05 Mitsubishi Pharma Corporation Pharmaceutical composition
JP2002241272A (ja) * 1996-07-18 2002-08-28 Mitsubishi Pharma Corp 医薬処方組成物
JPH11209277A (ja) * 1998-01-19 1999-08-03 Yoshitomi Pharmaceut Ind Ltd 医薬組成物
GB9711643D0 (en) * 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
JP2002523475A (ja) * 1998-09-02 2002-07-30 アラーガン・セイルズ・インコーポレイテッド 防腐したシクロデキストリン含有組成物
JP2001125052A (ja) * 1999-10-25 2001-05-11 Lion Corp コンタクトレンズ装着液
EP1312380B1 (en) * 2000-06-19 2006-05-03 Santen Pharmaceutical Co., Ltd. Aseptics
US6468989B1 (en) 2000-07-13 2002-10-22 Dow Pharmaceutical Sciences Gel compositions containing metronidazole
US6881726B2 (en) 2001-12-24 2005-04-19 Dow Pharmaceutical Sciences Aqueous compositions containing metronidazole
WO2006137433A1 (ja) * 2005-06-21 2006-12-28 Wakamoto Pharmaceutical Co., Ltd. レボカバスチンを可溶化させた水性薬剤
US20100069335A1 (en) * 2005-07-15 2010-03-18 Rajiv Bhushan Prevention and Treatment of Ophthalmic Complications of Diabetes
KR101875845B1 (ko) 2012-03-26 2018-07-06 산텐 세이야꾸 가부시키가이샤 디쿠아포솔 함유 점안액
CN112272578A (zh) * 2018-04-27 2021-01-26 阿勒根公司 抗微生物功效增强且毒性降低的亚氯酸钠组合物
EP4052694A4 (en) * 2019-11-21 2023-09-20 Samjin Pharmaceutical Co., Ltd. EYE DROPS COMPOSITION FOR PREVENTING OR TREATING EYE DISEASES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU602641B2 (en) * 1986-04-17 1990-10-18 Senju Pharmaceutical Co., Ltd. Thiolactam-N-acetic acid derivatives, their production and use

Also Published As

Publication number Publication date
RU2068260C1 (ru) 1996-10-27
JPH05213757A (ja) 1993-08-24
DE69109021D1 (de) 1995-05-24
KR920003971A (ko) 1992-03-27
FI97777B (fi) 1996-11-15
ATE121295T1 (de) 1995-05-15
HU207950B (en) 1993-07-28
NO913136L (no) 1992-02-14
FI913811A (fi) 1992-02-14
PT98643A (pt) 1992-07-31
HU912692D0 (en) 1992-01-28
HUT61196A (en) 1992-12-28
NO177845B (no) 1995-08-28
EP0472327A1 (en) 1992-02-26
US5663170A (en) 1997-09-02
TW200402B (no) 1993-02-21
AU8170891A (en) 1992-02-20
NO913136D0 (no) 1991-08-12
JP2769253B2 (ja) 1998-06-25
FI97777C (fi) 1997-02-25
PT98643B (pt) 1999-01-29
AU633754B2 (en) 1993-02-04
CA2048942A1 (en) 1992-02-14
DK0472327T3 (da) 1995-05-08
ES2071227T3 (es) 1995-06-16
FI913811A0 (fi) 1991-08-12
EP0472327B1 (en) 1995-04-19
DE69109021T2 (de) 1995-09-21

Similar Documents

Publication Publication Date Title
NO177845C (no) Fremgangsmåte for fremstilling av et preparat for öyedråper
NO179518C (no) AnalogifremgangsmÕte for fremstilling av 2- hydroksymetylcytosin-substituerte 1,3-oksatiolaner
DE69010139T2 (de) Haarkräftigungsmittel.
DE59100830D1 (de) Verfahren zur Herstellung von 3-Aminomethyl-3,5,5,-trimethyl-cyclohexylamin.
NO180084C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater
NO179612C (no) Analogifremgangsmåte for fremstilling av 3-arylkarbonyl-1-aminoalkyl-1H-indol-forbindelser
HUT47793A (en) Herbicide compositions containing 2,6-substituted-pyridine-carboxylic acid derivatives as active components and process for producing the active components
NO175976C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(1,6-dihydro-6-okso-pyridazinyl-3-oksy)-3-kromanolderivater
DE69209701D1 (de) Herstellung substituierter Tetrahydropyridine
NO301767B1 (no) Salt av clavulansyre
DE68923159T2 (de) Verfahren zur Herstellung von 1,4-Dihydropyridin-Derivaten.
DE59104649D1 (de) Verfahren zur Herstellung von N,N,N',N'-Tetraglycidyl-3,3'-dialkyl-4,4'-diaminodiphenylmethanen.
HUT57547A (en) Herbicidal compositions comprising n-phenylsulfonyl-n'-pyrimidinyl-urea derivatives as active ingredient and process for producing the active ingredient
ATE110061T1 (de) Optisch aktive 2,3-dihydrobenzoxazinderivate und verfahren zu deren herstellung.
DE69107897T2 (de) Verfahren zur Herstellung von N,N'-bis(tetrabromophthalimid).
HUT60737A (en) Process for producing new 1,4-dihydropyridine derivatives and pharmaceutical compositions comprising same as active ingredient
DE59105920D1 (de) Verfahren zur Herstellung von 5-Hydroxy-3,4,5,6-tetrahydro-pyrimidin-Derivaten.
IE840831L (en) 1,4-dihydropyridine derivatives
DE68922605T2 (de) Verfahren zur Herstellung von (-)2-(2-(2-Aminoethoxy)ethoxy)methyl)-4-(2,3-dichlorphenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridin, und Zwischenprodukt zu dessen Herstellung.
AU6791690A (en) Isomers of 1-azabicyclo(2.2.2)oct-3-yl 1,4-dihydro-2,6- dimethyl-4-(3-nitrophenyl)-5-nitropyridine-3-carboyxylate
BR8801794A (pt) Composicao fungicida e processo para a preparacao de derivados de 2-(o-alquila/substituido/)-2-tio-1,3,2-oxatiofosfolano
HU202246B (en) Fungicide compositions containing 2-(substituted)-aryl- or aryloxy- or arylthio-(alkyl- or alkoxy)-2-thio-1,3,2-oxathio-phospholane derivatives as active components and process for producing the active components
AU2486392A (en) Process for producing optically active 1,4-dihydropyridine compound
BR9105306A (pt) Processo para a producao de compostos n-aril-3-aril-4-substituido-2,3,4,5-tetra-hidro-1h-pirazol-1-carboxami da e composicao inseticida
NO172492C (no) Fremgangsmaate for fremstilling av alkalimetall- eller jordalkalimetallsalter av n5-formyl-5,6,7,8-tetrahydrofolsyre